Delivery and capacity constraints
Rapid order growth or uneven demand can overwhelm planning, manufacturing and installation resources.
- Scope
- Products and service implementation
- Materiality
- high
C-RAD
C-RAD is a Swedish medical technology company focused on surface-guided radiotherapy systems for cancer treatment. Its portfolio includes positioning, imaging and workflow solutions, plus service and support offerings sold to hospitals, clinics and distributors worldwide through the C-RAD group.
110
3.09
2.71
| % | |
|---|---|
| Positioning systems | 55% Hardware and software used to position patients precisely during radiotherapy. |
| Imaging systems | 10% Imaging and surface-scanning solutions that support treatment setup and monitoring. |
| Service and support | 25% Maintenance, upgrades, long-term contracts and technical support for installed systems. |
| Clinical training and consultancy | 5% Training and advisory services that help clinics use the systems effectively. |
| Distribution and other products | 5% Third-party or ancillary product sales and related offerings. |
C-RAD sells primarily to hospitals, cancer clinics and radiotherapy centers that need precise patient positioning and...
- Public hospitals and cancer clinicsprimary
Buy SGRT and positioning systems for radiotherapy departments that need precision and safety.
- Private oncology clinicssecondary
Buy systems and service packages to improve treatment workflow and patient experience.
- Reference clinicssecondary
Adopt and validate new workflows, helping support broader market acceptance.
- Distributors and channel partnerssecondary
Purchase or resell products in markets served indirectly by C-RAD.
- Installed-base service customersprimary
Buy maintenance, upgrades and training for existing C-RAD systems.
C-RAD sells globally, with products manufactured in Finland and distributed through direct sales and local partners...
- •Products are manufactured in Finland
- •Sales are global through direct channels and distributors
- •Revenue is spread across the Americas, EIMEA and APAC
- •Installed base worldwide supports recurring service revenue
- •Regional healthcare budgets affect order timing and demand
C-RAD’s strategy centers on expanding sales in established and new markets, investing in product development and...
01
International expansionmedium-term
Broader market coverage reduces dependence on a few regions and supports growth.
02
Service revenue growthshort-term
Recurring contracts improve customer retention and create a more stable revenue base.
03
Product developmentmedium-term
New and improved systems help maintain relevance in a technology-driven niche.
04
Operational executionshort-term
Reliable delivery and implementation are critical in a project-based medical device business.
C-RAD faces execution risk because demand spikes or slower-than-expected deliveries can disrupt order conversion and...
Dependence on external partners
Sales in some markets rely on distributors and cooperation agreements that may fail or change.
- Scope
- International sales channels
- Materiality
- high
Foreign exchange risk
Revenue and costs are spread across currencies, creating translation and transaction exposure.
- Scope
- Global operations
- Materiality
- medium
Cyber security risk
The business depends on data, software and connected clinical workflows that must remain secure.
- Scope
- Systems, data and reputation
- Materiality
- medium
Competition in radiotherapy technology
Larger competitors or adjacent players could invest heavily and pressure pricing or adoption.
- Scope
- SGRT and positioning systems
- Materiality
- high
Revenue recognition for products and services
Delivery timing and contract duration
Order backlog accounting
Visibility into future revenue conversion
Deferred tax assets
Balance sheet and tax expense
Impairment testing
Potential write-downs if assumptions weaken
Lease accounting
Balance sheet and EBITDA presentation
Contingent liabilities
Potential future cash outflows
: 11/08/2026